共 183 条
[1]
Azziz R(2009)The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 456-88
[2]
Carmina E(2004)The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2745-9
[3]
Dewailly D(2005)Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 90 1929-35
[4]
Azziz R(1999)Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 165-9
[5]
Woods KS(2010)Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes Fertil Steril 94 2493-6
[6]
Reyna R(2011)Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome Fertil Steril 95 2044-9
[7]
Key TJ(2009)The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes J Int Med Res 37 1803-12
[8]
Knochenhauer ES(1999)Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 79-83
[9]
Yildiz BO(2006)Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans Horm Metab Res 38 336-40
[10]
Apridonidze T(2000)Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 1595-9